JP2022500376A - タンパク質及びポリアルコキシ脂肪酸アシル界面活性剤を含む組成物 - Google Patents

タンパク質及びポリアルコキシ脂肪酸アシル界面活性剤を含む組成物 Download PDF

Info

Publication number
JP2022500376A
JP2022500376A JP2021513234A JP2021513234A JP2022500376A JP 2022500376 A JP2022500376 A JP 2022500376A JP 2021513234 A JP2021513234 A JP 2021513234A JP 2021513234 A JP2021513234 A JP 2021513234A JP 2022500376 A JP2022500376 A JP 2022500376A
Authority
JP
Japan
Prior art keywords
composition according
fatty acid
protein
acid acyl
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021513234A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500376A5 (https=
Inventor
エス． カッズ、ジョシュア
エル． ジョーダン、スーザン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Global Technologies LLC
Original Assignee
Dow Global Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies LLC filed Critical Dow Global Technologies LLC
Publication of JP2022500376A publication Critical patent/JP2022500376A/ja
Publication of JP2022500376A5 publication Critical patent/JP2022500376A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
JP2021513234A 2018-09-10 2019-09-06 タンパク質及びポリアルコキシ脂肪酸アシル界面活性剤を含む組成物 Pending JP2022500376A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862729140P 2018-09-10 2018-09-10
US62/729,140 2018-09-10
US201962850688P 2019-05-21 2019-05-21
US62/850,688 2019-05-21
PCT/US2019/049904 WO2020055679A2 (en) 2018-09-10 2019-09-06 A composition comprising a protein and a polyalkoxy fatty acyl surfactant

Publications (2)

Publication Number Publication Date
JP2022500376A true JP2022500376A (ja) 2022-01-04
JP2022500376A5 JP2022500376A5 (https=) 2023-05-12

Family

ID=68000095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021513234A Pending JP2022500376A (ja) 2018-09-10 2019-09-06 タンパク質及びポリアルコキシ脂肪酸アシル界面活性剤を含む組成物

Country Status (6)

Country Link
US (1) US20260115292A1 (https=)
EP (1) EP3849519B1 (https=)
JP (1) JP2022500376A (https=)
KR (1) KR20210056349A (https=)
CN (1) CN112672734B (https=)
WO (1) WO2020055679A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023506173A (ja) * 2019-12-12 2023-02-15 ニュートリション アンド バイオサイエンシス ユーエスエー １，エルエルシー タンパク質のバイオプロセス

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230242580A1 (en) * 2020-07-15 2023-08-03 Nutrition & Biosciences Usa 1, Llc Bioprocess with reduced fouling on surfaces

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017044367A1 (en) * 2015-09-11 2017-03-16 Dow Global Technologies Llc A composition comprising a protein and a polyalkoxy fatty compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005011608A1 (de) * 2005-03-14 2006-09-21 Basf Ag Veresterte Alkylalkoxylate als schaumarme Tenside
CN108771655A (zh) * 2011-10-28 2018-11-09 诚信生物公司 含有氨基酸的蛋白质制剂
CA2861402C (en) * 2012-01-30 2021-10-12 Guy Casy Stabilized aqueous antibody compositions
DK3347403T3 (da) 2015-09-11 2020-06-29 Dow Global Technologies Llc Polyalkoxyfedtforbindelse

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017044367A1 (en) * 2015-09-11 2017-03-16 Dow Global Technologies Llc A composition comprising a protein and a polyalkoxy fatty compound

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023506173A (ja) * 2019-12-12 2023-02-15 ニュートリション アンド バイオサイエンシス ユーエスエー １，エルエルシー タンパク質のバイオプロセス

Also Published As

Publication number Publication date
CN112672734A (zh) 2021-04-16
WO2020055679A3 (en) 2020-05-28
EP3849519A2 (en) 2021-07-21
US20260115292A1 (en) 2026-04-30
WO2020055679A2 (en) 2020-03-19
KR20210056349A (ko) 2021-05-18
CN112672734B (zh) 2023-04-11
EP3849519B1 (en) 2022-09-21

Similar Documents

Publication Publication Date Title
US11660343B2 (en) Viscosity-reducing excipient compounds for protein formulations
AU2013255413B2 (en) Pharmaceutical formulations of TNF-alpha antibodies
CN101969929B (zh) 粉末状蛋白质组合物及其制备方法
US11806399B2 (en) Excipient compounds for biopolymer formulations
AU7824201A (en) Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
TWI836745B (zh) 含有抗人類ｔｓｌｐ受體抗體之醫藥組成物
CA3129181C (en) Excipient compounds for biopolymer formulations
US20230065872A1 (en) Excipient compounds for protein processing
US10758621B2 (en) Liquid formulation comprising GM-CSF neutralizing compound
KR20190027878A (ko) 치료 단백질 제제용 안정화 부형제
US20260115292A1 (en) Composition comprising a protein and a polyalkoxy fatty acyl surfactant
CA3053909A1 (en) Excipient compounds for protein processing
CA3120023A1 (en) Excipient compounds for protein processing
US20210379185A1 (en) Excipient compounds for protein processing
JP6885875B2 (ja) 液体医薬組成物
JPS6016406B2 (ja) 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US20210322554A1 (en) A composition comprising a protein and a polyalkoxy fatty acyl surfactant
JPH0375533B2 (https=)

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20210312

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20210707

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230428

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230428

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230728

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230731

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240301